Identification of a novel bacterial sequence associated with Crohn's disease

Gastroenterology

Volumn 119, Issue 1, 2000, Pages 23-31

  Sutton, Christopher L ^a   Kim, Jeong ^a   Yamane, Akemi ^a   Dalwadi, Harnisha ^a   Wei, Bo ^a   Landers, Carol ^a,b   Targan, Stephan R ^a,b   Braun, Jonathan ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; BACTERIAL PROTEIN; GLUTATHIONE TRANSFERASE; HYBRID PROTEIN; IMMUNOGLOBULIN A;

ARTICLE; BACTERIAL GENETICS; CONTROLLED STUDY; CROHN DISEASE; DNA SEQUENCE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN TISSUE; ILEUM; IMMUNOREACTIVITY; INTESTINE MUCOSA; MAJOR CLINICAL STUDY; MOLECULAR CLONING; MYCOBACTERIUM; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; ULCERATIVE COLITIS;

EID: 0034235501     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2000.8519     Document Type: Article

References (46)

1. Binder S, Levitt AM, Sacks JJ, Hughes JM. Emerging infectious diseases: Public health issues for the 21st century. Science 1999;284:1311-1313.
2. Munkholm P. Crohn's disease: Occurrence, course and prognosis. An epidemiologic cohort-study. Dan Med Bull 1997;44:287-302.
3. Loftus EVJ, Silverstein MD, Sandborn WJ, Tremaine WJ, Harmsen WS, Zinsmeister AR. Crohn's disease in Olmsted County, Minnesota, 1940-1993: Incidence, prevalence, and survival. Gastroenterology 1998;114:1161-1168.
4. Blaser MJ, Miller RA, Lacher J, Singleton JW. Patients with active Crohn's disease have elevated serum antibodies to antigens of seven enteric bacterial pathogens. Gastroenterology 1984;87:888-894.
5. Elsaghier A, Prantera C, Moreno C, Ivanyi J. Antibodies to Mycobacterium paratuberculosis-specific protein antigens in Crohn's disease. Clin Exp Immunol 1992;90:503-508.
6. Vannuffel P, Dieterich C, Naerhuyzen B, Gilot P, Coene M, Fiasse R, Cocito C. Occurrence, in Crohn's disease, of antibodies directed against a species-specific recombinant polypeptide of Mycobacterium paratuberculosis. Clin Diag Lab Immunol 1994;1:241-243.
7. Wayne LG, Hollander D, Anderson B, Sramek HA, Vadheim CM, Rotter JI. Immunoglobulin A (IgA) and IgG serum antibodies to mycobacterial antigens in Crohn's disease patients and their relatives. J Clin Microbiol 1992;30:2013-2018.
8. Rath HC, Herfarth HH, Ikeda JS, Grenther WB, Hamm TE, Balish E, Taurog JD, Hammer RE, Wilson KH, Sartor RB. Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human β2 microglobulin transgenic rats. J Clin Invest 1996;98:945-953.
9. Dianda L, Hanby AM, Wright NA, Sebesteny A, Hayday AC, Owen MJ. T cell receptor-alpha,beta-deficient mice fail to develop colitis in the absence of a microbial environment. Am J Pathol 1997;150:91-97.
10. Rutgeerts P, Hiele M, Geboes K, Peeters M, Aerts R, Kerremans R. Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection [see comments]. Gastroenterology 1995;108:1617-1621.
11. Janowitz HD, Croen EC, Sachar DB. The role of the fecal stream in Crohn's disease: An historical and analytic review. Inflamm Bowel Dis 1998;4:29-39.
12. Sartor RB. The influence of normal microbial flora on the development of chronic mucosal inflammation. Res Immunol 1997;148:567-576.
13. Van Kruiningen HJ, Colombel JF, Cartun RW, Whitlock RH, Koopmans M, Kangro HO, Hoogkamp-Korstanje JAA, Lecomte-Houcke M, Devred M, Paris JC, Cortot A. An in-depth study of Crohn's disease in two French families. Gastroenterology 1993; 104:351-360.
14. Toyoda H, Wang S-J, Yang H-Y, Redford A, Magalong D, Tyan D, McElree C, Pressman S, Shanahan F, Targan SR, Rotter JI. Distinct associations of HLA class II genes with inflammatory bowel disease. Gastroenterology 1993;104:741-748.
15. Duerr RH, Barmada MM, Zhang L, Davis S, Preston RA, Chensny LJ, Brown JL, Ehrlich GD, Weeks DE, Aston CE. Linkage and association between inflammatory bowel disease and a locus on chromosome 12. Am J Hum Genet 1998;63:95-100.
16. Satsangi J, Parkes M, Louis E, Hashimoto L, Kato N, Welsh K, Terwilliger JD, Lathrop GM, Bell JI, Jewell DP. Two stage genomewide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12. Nat Genet 1996;14:199-202.
17. Plevy SE, Targan SR, Yang H-Y, Fernandez D, Rotter JI, Toyoda H. Tumor necrosis factor microsatellite define a Crohn's disease-associated haplotype on chromosome 6. Gastroenterology 1996; 110:1053-1060.
18. Ohmen JD, Yang H-Y, Yamamoto KK, Zhao HY, Ma Y, Bentley LG, Huang Z, Gerwehr S, Pressman S, McElree C, Targan SR, Rotter JI, Fischel-Ghodsian N. Susceptibility locus for inflammatory bowel disease on chromosome 16 has a role in Crohn's disease, but not in ulcerative colitis. Hum Mol Genet 1996;5:1679-1683.
19. Hugot J-P, Laurent-Puig P, Gower-Rousseau C, Olson JM, Lee JC, Beaugerie L, Naom I, Dupas J-L, Van Gossum A, Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives, Orholm M, Bonaiti-Pellie C, Weissenbach J, Mathew CG, Lennard-Jones JE, Cortot A, Colombel J-F, Thomas G. Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature 1996;379: 821-823.
20. Abel L, Dessein AJ. The impact of host genetics on susceptibility to human infectious diseases. Curr Opin Immunol 1997;9:509-516.
21. Relman DA. The search for unrecognized pathogens. Science 1999;284:1308-1311.
22. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994;266: 1865-1869.
23. Lisitsyn N, Wigler M. Cloning the difference between two complex genomes. Science 1993;259:946-951.
24. Boirivant M, Pica R, DeMaria R, Testi R, Pallone F, Strober W. Stimulated human lamina propria T cells manifest enhanced Fas-mediated apoptosis. J Clin Invest 1996;98:2616-2622.
25. Altschul SF, Gish W, Miller W, Meyers EW, Lippman DJ. Basic local alignment search tool. J Mol Biol 1990;215:403-410.
26. Goelz SE, Hamilton SR, Vogelstein B. Purification of DNA from formaldehyde fixed and paraffin embedded human tissue. Biochem Biophys Res Commun 1985;130:118-126.
27. Cottrez F, Auriault C, Capron A, Groux H. Quantitative PCR: Validation of the use of a multispecific internal control. Nucleic Acids Res 1994;22:2712-2713.
28. Finegold SM, Sutter VL. Fecal flora in different populations, with special reference to diet. Am J Clin Nutr 1978;1:S116-S122.
29. Guan K-L, Dixon JE. Eukaryotic proteins expressed in Escherichia coli: An improved thrombin cleavage and purification procedure of fusion proteins with glutathione S-transferase. Anal Biochem 1991;192:262-267.
30. Duchmann R, Kaiser I, Hermann E, Mayet W, Ewe K, Meyer ZB. Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD). Clin Exp Immunol 1995;102:448-455.
31. Khoo UY, Proctor IE, Macpherson AJ. CD4+ T cell down-regulation in human intestinal mucosa: Evidence for intestinal tolerance to luminal bacterial antigens. J Immunol 1997;158:3626-3634.
32. Main J, McKenzie H, Yeaman GR, Kerr MA, Robson DPCR, Parratt D. Antibody to Saccharomyces cerevisiae (bakers' yeast) in Crohn's disease. Br Med J 1988;297:1105-1106.
33. Quinton JF, Sendid B, Reumaux D, Duthilleul P, Cortot A, Grandbastien B, Charrier G, Targan SR, Colombel JF, Poulain D. Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: Prevalence and diagnostic role. Gut 1998;42:788-791.
34. Kam LY, Vasiliauskas EA, Landers C, Targan SR. Magnitude of response to Remicade correlates with marker antibody expression (abstr). Gastroenterology 1999;116:A744.
35. Cocito C, Gilot P, Coene M, De Kesel M, Poupart P, Vannuffel P. Paratuberculosis. Clin Microbiol Rev 1994;7:328-345.
36. El Zaatari FA, Naser SA, Hulten K, Burch P, Graham DY. Characterization of Mycobacterium paratuberculosis p36 antigen and its seroreactivities in Crohn's disease. Curr Microbiol 1999;39:115-119.
37. Suenaga K, Yokoyama Y, Nishimori I, Sano S, Morita M, Okazaki K, Onishi S. Serum antibodies to Mycobacterium paratuberculosis in patients with Crohn's disease. Dig Dis Sci 1999;44:1202-1207.
38. Green EP, Tizard ML, Moss MT, Thompson J, Winterbourne DJ, McFadden JJ, Hermon-Taylor J. Sequence and characteristics of IS900, an insertion element identified in a human Crohn's disease isolate of Mycobacterium paratuberculosis. Nucleic Acids Res 1989;17:9063-9073.
39. Del Prete R, Quaranta M, Lippolis A, Giannuzzi V, Mosca A, Jirillo E, Miragliotta G. Detection of Mycobacterium paratuberculosis in stool samples of patients with inflammatory bowel disease by IS900-based PCR and colorimetric detection of amplified DNA. J Microbiol Methods 1998;33:105-114.
40. Mishina D, Katsel P, Brown ST, Gilberts ECAM, Greenstein RJ. On the etiology of Crohn's disease. Proc Natl Acad Sci U S A 1996;93:9816-9820.
41. Francois B, Krishnamoorthy R, Elion J. Comparative study of Mycobacterium paratuberculosis strains isolated from Crohn's disease and Johne's disease using restriction fragment length polymorphism and arbitrarily primed polymerase chain reaction. Epidemiol Infect 1997;118:227-233.
42. Chiba M, Fukushima T, Horie Y, Iizuka M, Masamune O. No Mycobacterium paratuberculosis detected in intestinal tissue, including Peyer's patches and lymph follicles, of Crohn's disease. J Gastroenterol 1998;33:482-487.
43. Cellier C, De Beenhouwer H, Berger A, Penna C, Carbonnel F, Parc R, Cugnenc PH, Le Quintrec Y, Gendre JP, Barbier JP, Portaels F. Mycobacterium paratuberculosis and Mycobacterium avium subsp. silvaticum DNA cannot be detected by PCR in Crohn's disease tissue. Gastroenterol Clin Biol 1998;22:675-678.
44. Clarkston WK, Presti ME, Petersen PF, Zachary PEJ, Fan WX, Leonardi CL, Vernava AM, Longo WE, Kreeger JM. Role of Mycobacterium paratuberculosis in Crohn's disease: A prospective, controlled study using polymerase chain reaction. Dis Colon Rectum 1998;41:195-199.
45. Gui GPH, Thomas PRS, Tizard MLV, Lake J, Sanderson JD, Hermon-Taylor J. Two-year-outcomes analysis of Crohn's disease treated with rifabutin and macrolide antibiotics. J Antimicrob Chemother 1997;39:393-400.
46. Thomas GAO, Swift GL, Green JT, Newcombe RG, Braniff-Mathews C, Rhodes J, Wilkinson S, Strohmeyer G, Kreuzpainter G. Controlled trial of antituberculous chemotherapy in Crohn's disease: A five year follow up study. Gut 1998;42:497-500.